Peloton Therapeutics Email Format
Pharmaceutical ManufacturingTexas, United States51-200 Employees
Peloton Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Its lead programs target hypoxia-inducible factor-2α (HIF-2α), a transcription factor implicated in the development and progression of kidney cancer and other cancers. The company operates in the pharmaceutical manufacturing industry and is headquartered at 2330 Inwood Road Suite 226, Dallas, Texas 75235, United States, with a workforce of 51 to 200 employees. In January 2019, Merck acquired Peloton Therapeutics. The company maintains a website at https://pelotontherapeutics.com.
1-888-653-2347 
support@leadiq.com 
